Safety
Tesamorelin
Adverse-event report summary for Tesamorelin, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 10
- Reports flagged serious
- 8
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Depression3 reports
- Acute Kidney Injury2 reports
- Anxiety2 reports
- Feeling Abnormal2 reports
- Lipodystrophy Acquired2 reports
- Weight Decreased2 reports
- Abdominal Pain Upper1 reports
- Angiopathy1 reports
- Anhedonia1 reports
- Asthenia1 reports
- Basal Cell Carcinoma1 reports
- Blood Glucose Increased1 reports
- Blood Potassium Decreased1 reports
- Chronic Gastritis1 reports
- Chronic Kidney Disease1 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.